Research and Practice in Thrombosis and Haemostasis (Feb 2025)
Illustrated capsules from the Advanced Course in Platelet Research
- Christian Andrea Di Buduo,
- Vittorio Abbonante,
- Alessandro Malara,
- Alessandra Balduini,
- Amie K. Waller,
- Steve P. Watson,
- Eleyna M. Martin,
- Lloyd Bridge,
- Jonathan Gibbins,
- Ingeborg Hers,
- Claire Masson,
- Anita Eckly,
- Natalie S. Poulter,
- Beatriz Martínez-García,
- Sonia Aguila,
- Paolo Gresele,
- Stefania Momi,
- Paul Amstrong,
- Matthew Rondina,
- Sara Troitiño,
- Ángel García,
- José M. Bastida,
- Ana Marín Quilez,
- Ana Sánchez Fuentes,
- José Rivera,
- Raul Torres-Ruiz,
- Paula Ojeda-Walczuk,
- Neil V. Morgan,
- Belen de la Morena,
- Kato Ramaekers,
- My Tran,
- Koen De Wispelaere,
- Kathleen Freson,
- Wolfgang Bergmeier,
- Andreas Greinacher,
- Fan He,
- Stephen Oh,
- Jorge Di Paola,
- John W. Semple,
- María L. Lozano,
- Pilar Llamas,
- Chris Ward
Affiliations
- Christian Andrea Di Buduo
- Department of Molecular Medicine, University of Pavia, Pavia, Italy; Department of Biomedical Engineering, Tufts University, Medford, MA, USA
- Vittorio Abbonante
- Department of Molecular Medicine, University of Pavia, Pavia, Italy; Department of Biomedical Engineering, Tufts University, Medford, MA, USA
- Alessandro Malara
- Department of Molecular Medicine, University of Pavia, Pavia, Italy; Department of Biomedical Engineering, Tufts University, Medford, MA, USA
- Alessandra Balduini
- Department of Molecular Medicine, University of Pavia, Pavia, Italy; Department of Biomedical Engineering, Tufts University, Medford, MA, USA
- Amie K. Waller
- Department of Haematology, University of Cambridge, Cambridge, UK
- Steve P. Watson
- Department of Cardiovascular Sciences, College of Medicine and Health, University of Birmingham, UK; Steve P. Watson, Department of Cardiovascular Sciences, College of Medicine and Health, University of Birmingham, Edgbaston, IBR Building, Birmingham B15 2TT, UK.
- Eleyna M. Martin
- Department of Cardiovascular Sciences, College of Medicine and Health, University of Birmingham, UK
- Lloyd Bridge
- Department of Mathematics, University of the West of England, Frenchay Campus, Bristol, UK
- Jonathan Gibbins
- Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading, UK
- Ingeborg Hers
- School of Physiology, Pharmacology and Neuroscience, Biomedical Sciences Building, University of Bristol, Bristol, UK
- Claire Masson
- University of Strasbourg, INSERM, Etablissement Français du Sang (EFS) Grand-Est, UMR_S1255 Biologie et Pharmacologie des Plaquettes Sanguines (BPPS), FMTS, Strasbourg, France
- Anita Eckly
- University of Strasbourg, INSERM, Etablissement Français du Sang (EFS) Grand-Est, UMR_S1255 Biologie et Pharmacologie des Plaquettes Sanguines (BPPS), FMTS, Strasbourg, France
- Natalie S. Poulter
- Department of Cardiovascular Sciences, College of Medicine and Health, University of Birmingham, UK; Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, Midlands, UK
- Beatriz Martínez-García
- Centro Regional de Hemdonación, IMIB-Pascual Parrilla, Servicio de Hematología Hospital Universitario Morales Meseguer, Universidad de Murcia, Murcia, Spain
- Sonia Aguila
- Centro Regional de Hemdonación, IMIB-Pascual Parrilla, Servicio de Hematología Hospital Universitario Morales Meseguer, Universidad de Murcia, Murcia, Spain
- Paolo Gresele
- Department of Medicine and Surgery, Section of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy
- Stefania Momi
- Department of Medicine and Surgery, Section of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy
- Paul Amstrong
- Faculty of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, UK
- Matthew Rondina
- Huntsman Cancer Institute & Molecular Medicine Program, University of Utah Health, Salt Lake City, Utah, USA
- Sara Troitiño
- Center for Research in Molecular Medicine and Chronic Diseases (CiMUS) – Universidade de Santiago de Compostela, and Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain
- Ángel García
- Center for Research in Molecular Medicine and Chronic Diseases (CiMUS) – Universidade de Santiago de Compostela, and Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain
- José M. Bastida
- Department of Hematology, Complejo Asistencial Universitario de Salamanca (CAUSA), Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca (USAL), Salamanca, Spain; Grupo Español de Alteraciones Plaquetarias Congénitas (GEAPC), Spanish Society of Thrombosis and Haemostasis (SETH), Madrid, Spain
- Ana Marín Quilez
- Grupo Español de Alteraciones Plaquetarias Congénitas (GEAPC), Spanish Society of Thrombosis and Haemostasis (SETH), Madrid, Spain; Servicio de Hematología, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-U765, Murcia, Spain
- Ana Sánchez Fuentes
- Grupo Español de Alteraciones Plaquetarias Congénitas (GEAPC), Spanish Society of Thrombosis and Haemostasis (SETH), Madrid, Spain; Servicio de Hematología, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-U765, Murcia, Spain
- José Rivera
- Grupo Español de Alteraciones Plaquetarias Congénitas (GEAPC), Spanish Society of Thrombosis and Haemostasis (SETH), Madrid, Spain; Servicio de Hematología, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-U765, Murcia, Spain; Correspondence José Rivera, Servicio de Hematología, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación Murcia, Ronda de Garay s/n Murcia, Murcia 30003, Spain.
- Raul Torres-Ruiz
- Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
- Paula Ojeda-Walczuk
- Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain; Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain; Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain
- Neil V. Morgan
- Department of Cardiovascular Sciences, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK
- Belen de la Morena
- Servicio de Hematología, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-U765, Murcia, Spain
- Kato Ramaekers
- Department of Cardiovascular sciences, Center for Molecular and Vascular Biology, KULeuven, Belgium
- My Tran
- Department of Cardiovascular sciences, Center for Molecular and Vascular Biology, KULeuven, Belgium
- Koen De Wispelaere
- Department of Cardiovascular sciences, Center for Molecular and Vascular Biology, KULeuven, Belgium
- Kathleen Freson
- Department of Cardiovascular sciences, Center for Molecular and Vascular Biology, KULeuven, Belgium
- Wolfgang Bergmeier
- Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, USA; Blood Research Center, University of North Carolina, Chapel Hill, USA
- Andreas Greinacher
- Institut für Transfusionsmedizin Universitätsmedizin Greifswald, Greifswald, Germany
- Fan He
- Department of Medicine and Pediatrics, Washington University School of Medicine in Saint Louis, Saint Louis, MO, USA
- Stephen Oh
- Department of Medicine and Pediatrics, Washington University School of Medicine in Saint Louis, Saint Louis, MO, USA
- Jorge Di Paola
- Department of Medicine and Pediatrics, Washington University School of Medicine in Saint Louis, Saint Louis, MO, USA
- John W. Semple
- Division of Hematology and Transfusion Medicine, Lund University, Dept. of Pharmacology, University of Toronto, Toronto, Canada
- María L. Lozano
- Servicio de Hematología, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-U765, Murcia, Spain
- Pilar Llamas
- Hematology and Hemotherapy Services at the Fundación Jiménez Díaz University Hospitals, Rey Juan Carlos Hospital, and Infanta Elena Hospital, Universidad Autónoma de Madrid, Madrid, Spain
- Chris Ward
- Cancer Haematology and Palliative Care, Royal North Shore Hospital, Sydney Clinical School, University of Sydney, Sydney, Australia
- DOI
- https://doi.org/10.1016/j.rpth.2025.102715
- Journal volume & issue
-
Vol. 9,
no. 2
p. 102715
Abstract
This series of illustrated capsules summarizes the presentations made by the speakers at the first International Advanced Course in Platelet Research held in Murcia (Spain) from 27 to 28 September, 2024. This is the first course to receive a Fundamental Research Workshop Grant from the International Society on Thrombosis and Haemostasis (ISTH) and was also supported administratively and scientifically by the Spanish Society of Thrombosis and Haemostasis (SETH). This unique course focused on new methodologies applied in platelet research and how these are increasing our understanding of platelet formation, their multifunctionality in different physiological and pathological contexts, and contributing to the development of new platelet-targeted therapies to improve the management of hemostatic/thrombotic pathologies. It aligns with the objectives of several Scientific and Standardization Committees of the ISTH, including Platelet Physiology and Genomics in Thrombosis and Haemostasis, as well as with the academic objectives of the ISTH and SETH. The program was designed by the coordinator (J. Rivera), and the scientific advisory board (SAB: S.P. Watson, K. Freson, A. Balduini, and J. Di Paola) and comprised 9 scientific sessions with 25 presentations, each with time for extensive open discussion. Additionally, 33 abstract posters were presented, with the 3 highest scoring selected as oral presentations. The course was held in a single location and with an informal atmosphere to facilitate networking among participants. The course received very positive feedback from the 140 attendees. The course was supported by the ISTH, SETH, University of Murcia, CIBERER-ISCIII, Fundación Séneca (22426/OC/24), the United Kingdom Platelet Society and various pharmaceutical companies. We believe that the extraordinary scientific and human experience of this course may act as a stimulus for future courses.
